Ceppi F

ORCID: 0000-0002-9665-3190 · 1 paper in corpus

2017

Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.

Oncotarget ·doi:10.18632/oncotarget.17959

Allergy, pancreatitis and thrombosis are common side-effects of childhood acute lymphoblastic leukemia (ALL) treatment that are associated with the use of asparaginase (ASNase), a key component in most ALL treatment protocols. Starting with…